Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Pittsburgh
With
GE Healthcare
Age
18–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
18 years of age or older
Women who have indeterminate mammographic or sonographic findings who are recommended and for biopsy
You may not be if
Known contraindication to mammographic imaging
women who are pregnant
women who are lactating
women who have significant existing breast trauma
women who have breast implants
Women under 18 years of age.
women who had previous benign breast surgery within 1 year
Males and children
Women who are unable to understand or execute written informed consent
Women who refuse to have a biopsy
Women with any known renal disease - if an MRI is deemed necessary, a serum creatine will be checked prior to injection of contrast. Using the National Kidney Foundation recommendations, a glomerular filtration rate (GFR) greater than 60 may safely receive intravenous gadolinium-based MRI contrast. Those individuals with a GFR \>30 and \<60 can receive the contrast but at a reduced dose (typically half). Those with a GFR \<30 will not receive MRI contrast and will not undergo the exam. Breast MRI must be done with contrast if evaluating for cancer. Several factors can affect the GFR such as age, body size, creatinine, renal status and will be calculated from the blood drawn. GFR is the final determinant and a creatinine greater than 1.6 usually has a GFR that precludes a Breast MRI with contrast. The final determinant will be the GFR.
Clareo Health | The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
